Protein Summary
In adipose tissue and heart, it primarily hydrolyzes stored triglycerides to free fatty acids, while in steroidogenic tissues, it principally converts cholesteryl esters to free cholesterol for steroid hormone production. The protein encoded by this gene has a long and a short form, generated by use of alternative translational start codons. The long form is expressed in steroidogenic tissues such as testis, where it converts cholesteryl esters to free cholesterol for steroid hormone production. The short form is expressed in adipose tissue, among others, where it hydrolyzes stored triglycerides to free fatty acids. [provided by RefSeq, Jul 2008]
- ENST00000244289
- ENSP00000244289
- ENSG00000079435
- HSL
- LHS
- AOMS4
- FPLD6
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
metabolite | 1 | ||
kinase | 0.85 | ||
gene perturbation | 0.82 | ||
biological term | 0.76 | ||
disease perturbation | 0.74 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 457.01 (req: < 5)
Gene RIFs: 60 (req: <= 3)
Antibodies: 435 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 457.01 (req: >= 5)
Gene RIFs: 60 (req: > 3)
Antibodies: 435 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 10
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligands: 284
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0